Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorTHOMAS, Quentin Dominique
dc.contributor.authorBASSE, Clemence
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBELAROUSSI, Yaniss
dc.contributor.authorBEAUCAIRE-DANEL, Sophie
dc.contributor.authorDANIEL, Catherine
dc.contributor.authorQUANTIN, Xavier
dc.contributor.authorGIRARD, Nicolas
dc.date.accessioned2023-03-13T09:03:11Z
dc.date.available2023-03-13T09:03:11Z
dc.date.issued2022-06-01
dc.identifier.issn2666-3643, 2666-3643en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/172266
dc.description.abstractEnIntroductio : Telehealth is taking an increasingly important part of medicine. This practice change is being accelerated by the pandemic linked to coronavirus disease 2019. Oncology is a medical specialty for which this paradigm shift is particularly relevant. Method : We developed a survey aiming at evaluating the use of teleconsultation by physicians managing patients with lung cancer in France. The survey was available online from December 15, 2020, to February 10, 2021. Result : Answers were obtained from 142 clinicians (73.9% pneumologists, 18.3% medical oncologists, and 7.7% with another specialty), 129 (90.8%) of whom had already performed teleconsultation. Among those, 123 (95.3%) started after the coronavirus disease 2019 pandemic. In addition, 72.9% had a moderate usage of this tool (<10 teleconsultations/mo). The frequency of clinicians never using teleconsultation was higher in private practices (p = 0.029). The two clinical situations for which teleconsultation was frequently used were visits during treatment without imaging assessment (53.5%) and post-treatment surveillance (80.3%). Depending on the type of treatment received, the frequency of teleconsultation was variable. Lung cancer subtype also affected the clinician's practice. Indeed, 47.2% never proposed this tool for SCLC. Teleconsultation was considered to be of no contribution, a moderate contribution, a significant contribution, or a revolution of the clinical practice for 14.1%, 66.2%, 10.6%, and 2.1% of the respondents, respectively. The participants expected to decrease, stabilize, or increase their teleconsultation activity in 18.3%, 52.8%, and 23.2% of the cases, respectively. Conclusions : Most thoracic oncologists in France are using teleconsultation, mostly as an additional tool that should not replace the doctor-patient in-person relationship.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subject.enE-health
dc.subject.enLung cancer
dc.subject.enSurvey
dc.subject.enTelemedicine
dc.subject.enThoracic oncology
dc.title.enBrief Report on Teleconsultation in Lung Cancer: Toward a Semiotic Paradigm Shift?
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jtocrr.2022.100333en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35677683en_US
bordeaux.journalJTO Clinical and Research Reportsen_US
bordeaux.volume3en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue6en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEPICENE_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=JTO%20Clinical%20and%20Research%20Reports&amp;rft.date=2022-06-01&amp;rft.volume=3&amp;rft.issue=6&amp;rft.eissn=2666-3643,%202666-3643&amp;rft.issn=2666-3643,%202666-3643&amp;rft.au=THOMAS,%20Quentin%20Dominique&amp;BASSE,%20Clemence&amp;BELAROUSSI,%20Yaniss&amp;BEAUCAIRE-DANEL,%20Sophie&amp;DANIEL,%20Catherine&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée